Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment?
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment?
By Todd Campbell
September 13, 2014
One of the most contentious debates surrounding medical marijuana is whether its use could help millions of people suffering from schizophrenia. For decades, the conventional wisdom has been that marijuana, at a minimum, triggers the disease, or at a maximum, causes it. However, research conducted over the past decade is prompting many to question that long-standing belief.
That research has found that while THC, the marijuana cannibinoid responsible for the “high,” can hasten the onset of schizophrenia, CBD, another marijuana cannibinoid, may reduce symptoms. That research has compelled U.K. drugmaker GW Pharmaceuticals (NASDAQ: GWPH ) to develop a synthetic variation of CBD that it is studying in clinical trials as a schizophrenia treatment.
Related News
Does cannabis help or hurt the immune system?
Does cannabis help or hurt the immune system? Emma Stone | September 17, 2020 CannabisRead More
Rolling Papers May Not Be as Safe as We Think
Rolling Papers May Not Be as Safe as We Think Lori Ann Reese | 09/04/2020Read More
Comments are Closed